Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2022-11-11 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Financial Results for the quarter and six months ended September 30, 2022
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement dated November 11, 2022, from Unichem Laboratories Limited regarding the approval of unaudited financial results for the quarter and half year ended September 30, 2022. It includes comprehensive financial data such as revenue, expenses, profit/loss, tax details, earnings per share, and notes explaining accounting standards and contingent liabilities. The presence of unaudited standalone financial results with substantive financial data and analysis for a period shorter than a full fiscal year (quarter and half year) indicates this is an Interim / Quarterly Report. The document is not merely an announcement of a report or a certification but contains actual financial statements and detailed notes. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-11-11 English
UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve Board meeting on 11.11.2022 ....
Board/Management Information Classification · 95% confidence The document is a notice from Unichem Laboratories Limited informing the Bombay Stock Exchange and National Stock Exchange of India about an upcoming Board Meeting scheduled for November 11, 2022. The purpose of the meeting is to consider and approve the unaudited financial results for the second quarter and six months ended September 30, 2022. The document also mentions the closure of the trading window for insiders in compliance with insider trading regulations. The document is a formal announcement of a board meeting and does not contain any financial results or detailed reports itself. It is not a full financial report, earnings release, or management discussion. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related information.
2022-11-03 English
Board Meeting — Financial results
Board/Management Information Classification · 95% confidence The document is a notice from Unichem Laboratories Limited informing the stock exchanges about a scheduled Board Meeting to consider and approve unaudited financial results for the second quarter and six months ended September 30, 2022. It is a formal announcement of a board meeting date and agenda, not the financial results themselves or any detailed report. The document is short (1746 characters) and serves as a notification rather than a report or detailed filing. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related management information.
2022-11-03 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding compliance with Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It specifically informs about the loss/misplacement of share certificates and the issuance of duplicate certificates. There is no financial data, no report attached or referenced as being published, and no mention of earnings, management changes, or other report types. This is a regulatory compliance notification related to share certificate loss, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2022-10-21 English
Details of Loss of Certificate / Duplicate Certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding compliance with Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the loss/misplacement of share certificates and the issuance of duplicate certificates. The content is a regulatory notification related to share certificate status, not a financial report, earnings release, or management discussion. It does not contain financial data or detailed report content but is a compliance announcement to stock exchanges. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-10-21 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding compliance with Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides an intimation about the loss/misplacement of share certificates and the process for issuing duplicate certificates. The content is a regulatory notification related to share certificate status rather than a financial report, management change, or shareholder meeting material. The document length is short (1735 characters) and it is an official regulatory communication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-10-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.